Development of Swiss Biotechnology Beyond the Biopharmaceutical Sector In memoriam Prof. Dr. Oreste Ghisalba (1946–2018)

Although diverse, the potential business opportunities for biotechnology outside the biopharmaceutical market are very large. White biotechnology can offer sustainable operations and products, while investments tend to be lower than those in red biotechnology. But a number of bottlenecks and roadblo...

Full description

Bibliographic Details
Main Authors: Hans-Peter Meyer, Oleg Werbitzky
Format: Article
Language:deu
Published: Swiss Chemical Society 2020-05-01
Series:CHIMIA
Subjects:
Online Access:https://www.ingentaconnect.com/contentone/scs/chimia/2020/00000074/00000005/art00006